tiprankstipranks
Trending News
More News >
Solvonis Therapeutics plc (GB:SVNS)
:SVNS
Advertisement

Solvonis Therapeutics (SVNS) Revenue

Compare
10 Followers

Solvonis Therapeutics Revenue

Solvonis Therapeutics had a revenue of 0.00 in the quarter ending Dec 31, 2024, with ―. This bring the company's revenue in the last twelve months to 0.00, Increased -100.00%. In the fiscal year ending Dec 31, 2023, Solvonis Therapeutics had annual revenue of 587.00K with 8.30% growth.
Revenue (ttm)
0.00
Revenue Growth
P/S Ratio
33.86
Revenue/Employee
£195,667
Employees
3
Market Cap
£19.87M

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2023
587.00K45.00K+108.30%
Dec 31, 2022
542.00K323.00K+247.49%
Dec 31, 2021
219.00K-471.86K+31.70%
Dec 31, 2020
690.86K360.86K+209.35%
Dec 31, 2019
330.00K301.00K+1,137.97%
Dec 31, 2018
29.00K
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis